AHEAD

We developed two algorithms using state-of-art artificial intelligence: - Residual Disease Detection: an advanced algorithm to perform multicolor flow cytometry analysis on bone marrow specimens of acute leukemia patients. - Relapse and Mortality Prediction: comprehensive risk stratification and outcome prediction models for acute myeloid leukemia patients using historical examination and treatment records.